首页 News 正文

GlaxoSmithKline immunotherapy approved by the European Union for the treatment of endometrial cancer

穿越夜时空簿
1338 0 0

GlaxoSmithKline announced on December 11th that the European Commission has approved the use of Dostarlimab (Jemperli) in combination with carboplatin and paclitaxel for the treatment of primary advanced or recurrent endometrial cancer carrying mismatch repair defects (dMMR) or high microsatellite instability (MSI-H).
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

穿越夜时空簿 新手上路
  • 粉丝

    0

  • 关注

    0

  • 主题

    3